SCHEMBL3607269

SCHEMBL3607269

O=[N+]([O-])c1c[nH]c(S)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28920099 0.77 ALDH1A1 (0.33)
SCHEMBL64072 0.77 CYP3A4 (0.33)
SCHEMBL9627673 0.76
SCHEMBL28819045 0.76 CYP3A4 (0.32)
SCHEMBL27960253 0.76 CYP3A4 (0.32)
SCHEMBL28013221 0.76 CYP3A4 (0.32)
SCHEMBL28013804 0.76 CYP3A4 (0.32)
SCHEMBL2302179 0.74
SCHEMBL58560 0.74
SCHEMBL7555586 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2644599-A1 Method for preparing 1-substituted-4-nitroimidazole compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-10-02 EP disclosed
US-20100048555-A1 IMIDAZOTHIAZOLE DERIVATIVES AS MARK INHIBITORS MERCK SHARP & DOHME LIMITED (GB) 2010-02-25 US disclosed
EP-2046803-A1 IMIDAZOTHIAZOLE DERIVATIVES AS MARK INHIBITORS Merck Sharp &amp; Dohme Limited (GB) 2009-04-15 EP disclosed
WO-2008012571-A1 IMIDAZOTHIAZOLE DERIVATIVES AS MARK INHIBITORS MERCK SHARP & DOHME LIMITED (GB) 2008-01-31 WO disclosed